Request Legal Help Now - Free

Advertisement
LAWSUITS NEWS & LEGAL INFORMATION

GlaxoSmithKline Sales Rep California Overtime


A lawsuit was filed on behalf of GlaxoSmithKline sales reps alleging they were misclassified as exempt from California overtime and should have been paid overtime for their work as California GlaxoSmithKline sales representatives. Although the California GlaxoSmithKline sales representatives lawsuit resulted in a verdict for the defendant, other similar lawsuits filed against different companies have resulted in victories for the pharmaceutical sales representatives. Lawsuits involving California pharmaceutical sales representatives have been filed, alleging pharmaceutical companies violated California overtime law by misclassifying California sales reps as exempt from overtime.

FREE GSK SALES REP CALIFORNIA OVERTIME LAWSUIT EVALUATION

Send your GSK Sales Rep California Overtime claim to a lawyer who will review your claim at NO COST or obligation.
GET LEGAL HELP NOW

California Overtime and GlaxoSmithKline Sales Representatives

Under California overtime law, employees are entitled to one-and-one-half times the regular rate of pay for all hours worked that are in excess of eight hours in a workday. Furthermore, under both California overtime laws and the Fair Labor Standards Act (FLSA), employees are entitled to overtime pay for working more than 40 hours in a workweek.

California GlaxoSmithKline Pharmaceutical Sales and the Fair Labor Standards Act

darvonanddarvocet Under the Fair Labor Standards Act (FLSA), people who are involved in outside sales are typically considered exempt from overtime pay. That is because people involved in outside sales have unlimited earning potential due to their commissions—the more they sell, the more they can make.

California GlaxoSmithKline Sales Overtime Pay

For a long time, pharmaceutical sales representatives were considered exempt from overtime pay. They could be considered exempt on one of two counts: either as outside sales people or under the administrative exemption, if they have discretion and authority in their job.

Some recent lawsuits, however, have resulted in the courts determining that some pharmaceutical sales reps are not exempt from overtime pay—that is, they should be paid overtime for their hours worked—because they do not fall under either the outside sales exemption or the administrative exemption.

California GlaxoSmithKline Sales Representative Overtime Lawsuit

pharmasalesrep A lawsuit filed against GlaxoSmithKline alleged that GlaxoSmithKline sales representatives should be paid overtime because they do not meet the requirements for overtime exemption. The Ninth Circuit Court of Appeals found that GSK sales representatives are not entitled to overtime because they are defined as "salesmen," filling the requirement for outside sales exemption.

This finding contradicts the Second Circuit Court of Appeals, which found in the Novartis sales representative lawsuit that Novartis sales representatives should be eligible for overtime pay because their job is not directly involved in sales.

The judges in the GlaxoSmithKline sales representative lawsuit found that some salespeople earned compensation that made up to 41 percent of their gross income, making them ineligible for overtime pay. Outside sales people are considered exempt from overtime because commissions and incentives mean their earning potential is virtually unlimited.

GSK Sales Rep California Overtime Legal Help

If you or a loved one has suffered damages in this case, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.


Last updated on

GSK SALES REP CALIFORNIA OVERTIME LEGAL ARTICLES AND INTERVIEWS

GlaxoSmithKline Sales Boost Projected After Approval of New Drug
GlaxoSmithKline Sales Boost Projected After Approval of New Drug
March 18, 2011
The first new treatment for the disease lupus in half a century recently received US Food and Drug Administration (FDA) approval and is expected to significantly aid GlaxoSmithKline sales, Reuters reports.  READ MORE

ADD YOUR COMMENT ON THIS ISSUE

Please read our comment guidelines before posting.


Note: Your name will be published with your comment.


Your email will only be used if a response is needed.

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Request Legal Help Now! - Free